China Biologic Produ
(CBPO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 93,261 | 44,624 | 147,967 | 109,266 | 71,611 |
| Depreciation Amortization | 12,511 | 6,399 | 23,225 | 18,201 | 11,727 |
| Income taxes - deferred | -2,054 | -383 | -4,160 | -6,120 | -4,315 |
| Accounts receivable | -15,233 | -11,554 | -53,880 | -47,683 | -30,299 |
| Accounts payable and accrued liabilities | -4,500 | -5,544 | 8,141 | 2,612 | -1,322 |
| Other Working Capital | -19,038 | -25,594 | -88,276 | -74,199 | -49,299 |
| Other Operating Activity | 29,285 | 24,217 | 70,925 | 68,961 | 47,436 |
| Operating Cash Flow | $94,232 | $32,166 | $103,942 | $71,037 | $45,541 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 805,630 | 536,621 | 1,262,530 | 359,293 | -40,833 |
| PPE Investments | -12,730 | -5,468 | -31,619 | -26,166 | -18,426 |
| Net Acquisitions | N/A | N/A | 97,702 | 97,702 | 97,702 |
| Purchase Of Investment | -908,003 | -743,412 | -1,882,586 | -1,116,355 | -206,656 |
| Purchase Sale Intangibles | -2,385 | -2,454 | -4,973 | -701 | -701 |
| Other Investing Activity | -2,385 | -2,454 | -4,973 | -700 | -701 |
| Investing Cash Flow | $-117,489 | $-214,713 | $-558,945 | $-686,226 | $-168,914 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 237 | 4 | 591,450 | 591,446 | 767 |
| Dividend Paid | -5,062 | N/A | -10,145 | N/A | N/A |
| Other Financing Activity | -110,043 | -60,000 | -10,000 | -10,145 | 0 |
| Financing Cash Flow | $-114,868 | $-59,996 | $571,304 | $581,301 | $767 |
| Exchange Rate Effect | 1,696 | 2,677 | 3,243 | 967 | 6,568 |
| Beginning Cash Position | 338,881 | 338,881 | 219,337 | 219,337 | 219,337 |
| End Cash Position | 202,451 | 99,014 | 338,881 | 186,415 | 103,299 |
| Net Cash Flow | $-136,430 | $-239,866 | $119,544 | $-32,922 | $-116,038 |
| Free Cash Flow | |||||
| Operating Cash Flow | 94,232 | 32,166 | 103,942 | 71,037 | 45,541 |
| Capital Expenditure | -12,732 | -5,468 | -31,743 | -26,193 | -18,444 |
| Free Cash Flow | 81,500 | 26,697 | 72,199 | 44,844 | 27,097 |